All Phenotypes Cfl1<tm1.1Wit> MGI Mouse

Phenotypes associated with this allele

Jump to	Allelic Composition	Genetic Background	Genotype ID
cn1	Cfl1^tm1.1Wit/Cfl1^tm1.1Wit	involves: 129 * C57BL/6 * SJL	MGI:4943295
cn2	Cfl1^tm1.1Wit/Cfl1⁺ Dstn^tm1.1Wit/Dstn^tm1.1Wit Tg(Nes-cre)1Kln/0	involves: 129 * BALB/cJ * C57BL/6 * SJL	MGI:4943294
cn3	Cfl1^tm1.1Wit/Cfl1^tm1.1Wit Tg(NPHS2-cre)295Lbh/0	involves: 129 * C57BL/6 * SJL	MGI:5432555
cn4	Cap1^tm1.1Mbrst/Cap1^tm1.1Mbrst Cfl1^tm1.1Wit/Cfl1^tm1.1Wit Tg(Nes-cre)1Kln/0	involves: 129 * C57BL/6 * SJL	MGI:7443115

♀	phenotype observed in females
♂	phenotype observed in males
N	normal phenotype

mortality/aging

premature death ( J:125317 )

• rare survivors die by P30

postnatal lethality, incomplete penetrance ( J:125317 )

• nearly all mice die by between P1 and P3

nervous system

seizures ( J:125317 )

• in rare survivors

abnormal neuron differentiation ( J:125317 )

• neuronal progenitors exit the cell cycle prematurely and differentiate

abnormal axon extension ( J:125317 )

• neurite outgrowth is impaired compared to in wild-type mice

premature neuronal precursor differentiation ( J:125317 )

• between E13 and E19, neuronal progenitor cells in the ventricular zone exhibit a migratory defect that prevents them from entering intermediate layers unlike in wild-type mice

• at E18, radial migration of proliferating cells into the cortex is impaired compared to in wild-type mice

• neuronal progenitors fail to reach the medial pallium unlike in wild-type mice

• interkinetic nuclear migration in the ventricular zone is impaired compared to in wild-type mice

abnormal neuronal precursor proliferation ( J:125317 )

• at E14 and E16, mice exhibit impaired cell proliferation of cells in the ventricular zone compared to in wild-type mice

enlarged brain ventricles ( J:125317 )

abnormal cerebral cortex morphology ( J:125317 )

• large parts of layers II, III, and IV are missing compared with wild-type mice

• however, the upper molecular layer I and the inner multiform layer VI are present

abnormal neurite morphology ( J:125317 )

• neurites are shorter than in wild-type cells

behavior/neurological

ataxia ( J:125317 )

• in rare survivors

seizures ( J:125317 )

• in rare survivors

growth/size/body

postnatal growth retardation ( J:125317 )

• in rare survivors

cellular

abnormal neuron differentiation ( J:125317 )

• neuronal progenitors exit the cell cycle prematurely and differentiate

abnormal axon extension ( J:125317 )

• neurite outgrowth is impaired compared to in wild-type mice

premature neuronal precursor differentiation ( J:125317 )

• between E13 and E19, neuronal progenitor cells in the ventricular zone exhibit a migratory defect that prevents them from entering intermediate layers unlike in wild-type mice

• at E18, radial migration of proliferating cells into the cortex is impaired compared to in wild-type mice

• neuronal progenitors fail to reach the medial pallium unlike in wild-type mice

• interkinetic nuclear migration in the ventricular zone is impaired compared to in wild-type mice

abnormal neuronal precursor proliferation ( J:125317 )

• at E14 and E16, mice exhibit impaired cell proliferation of cells in the ventricular zone compared to in wild-type mice

Allelic Composition	Cfl1^tm1.1Wit/Cfl1⁺ Dstn^tm1.1Wit/Dstn^tm1.1Wit Tg(Nes-cre)1Kln/0
Genetic Background	involves: 129 * BALB/cJ * C57BL/6 * SJL

Find Mice

Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Cfl1^tm1.1Wit mutation (0 available); any Cfl1 mutation (26 available)
Dstn^tm1.1Wit mutation (0 available); any Dstn mutation (43 available)
Tg(Nes-cre)1Kln mutation (4 available)

♀	phenotype observed in females
♂	phenotype observed in males
N	normal phenotype

normal phenotype

no abnormal phenotype detected ( J:125317 )

• mice are viable and phenotypically normal

Allelic Composition	Cfl1^tm1.1Wit/Cfl1^tm1.1Wit Tg(NPHS2-cre)295Lbh/0
Genetic Background	involves: 129 * C57BL/6 * SJL

Find Mice

Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Cfl1^tm1.1Wit mutation (0 available); any Cfl1 mutation (26 available)
Tg(NPHS2-cre)295Lbh mutation (3 available)

♀	phenotype observed in females
♂	phenotype observed in males
N	normal phenotype

mortality/aging

premature death ( J:165315 )

• mice exhibit a reduced life span with a median age at death of 9 months

homeostasis/metabolism

increased circulating creatinine level ( J:165315 )

• significant increase in serum creatinine levels at 6 months of age, indicating renal dysfunction

ascites ( J:165315 )

• large ascites detected at 9 months of age

increased urine protein level ( J:165315 )

• mice develop persistent proteinuria by 3 months of age

• rate of proteinuria increases modestly until 6 months and accelerates more rapidly thereafter

abnormal response to injury ( J:165315 )

• after induction of kidney podocyte injury by protamine sulfate (PS) perfusion, mutant foot processes exhibit a broadened and flattened morphology that is distinct from that in wild-type controls

• PS-treated mutant podocytes develop unusually long fine processes that project from primary, secondary, and tertiary processes, suggesting pseudovillous transformation

• PS-treated mutant podocytes fail to recover normal morphology following subsequent infusion of heparin sulfate, unlike wild-type controls

renal/urinary system

renal/urinary system phenotype ( J:165315 )

N	• mice exhibit no evidence of glomerular or interstitial scarring, even at 9 months of age

increased urine protein level ( J:165315 )

• mice develop persistent proteinuria by 3 months of age

• rate of proteinuria increases modestly until 6 months and accelerates more rapidly thereafter

abnormal podocyte foot process morphology ( J:165315 )

• mice exhibit evidence of fine finger-like projections from the podocyte cell bodies and processes at 6 months of age

• foot process spreading is evident by 8 months of age

• following PS perfusion, foot processes exhibit a broadened and flattened morphology that is distinct from that in wild-type controls

podocyte microvillus transformation ( J:165315 )

• PS-treated podocytes develop unusually long fine processes that project from primary, secondary, and tertiary processes, suggesting pseudovillous transformation

• PS-treated mutant podocytes fail to recover normal morphology following subsequent infusion of heparin sulfate, unlike wild-type controls

integument

disheveled coat ( J:165315 )

• mice exhibit a scruffed appearance at 9 months of age

Allelic Composition	Cap1^tm1.1Mbrst/Cap1^tm1.1Mbrst Cfl1^tm1.1Wit/Cfl1^tm1.1Wit Tg(Nes-cre)1Kln/0
Genetic Background	involves: 129 * C57BL/6 * SJL

Find Mice

Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Cap1^tm1.1Mbrst mutation (0 available); any Cap1 mutation (32 available)
Cfl1^tm1.1Wit mutation (0 available); any Cfl1 mutation (26 available)
Tg(Nes-cre)1Kln mutation (4 available)

♀	phenotype observed in females
♂	phenotype observed in males
N	normal phenotype

cellular

impaired neuron differentiation ( J:333563 )

• impaired growth cone morphology and motility

nervous system

impaired neuron differentiation ( J:333563 )

• impaired growth cone morphology and motility

Contributing Projects: Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources Funding Information Warranty Disclaimer, Privacy Notice, Licensing, & Copyright Send questions and comments to User Support.	last database update 12/10/2024 MGI 6.24